Medicine & Life Sciences
phthalan
100%
Citalopram
58%
Serotonin Plasma Membrane Transport Proteins
58%
Structure-Activity Relationship
54%
D3 compound
44%
Non-Small Cell Lung Carcinoma
34%
Piperazine
33%
Immunotherapy
27%
Protein Kinase Inhibitors
24%
Binding Sites
21%
Anaplastic Lymphoma Kinase
20%
Lung Neoplasms
18%
Biomarkers
15%
Phosphotransferases
15%
ErbB Receptors
14%
Norepinephrine Plasma Membrane Transport Proteins
11%
Antidepressive Agents
10%
In Vitro Techniques
10%
Neoplasms
10%
Dopamine Plasma Membrane Transport Proteins
9%
Comorbidity
9%
Allosteric Site
8%
Leucine
7%
rociletinib
7%
Tumor Burden
7%
Proteomics
7%
PF 00299804
7%
Ligands
6%
Patient Selection
6%
Therapeutics
5%
Crizotinib
5%
Immunohistochemistry
5%
MAP Kinase Kinase Kinases
5%
Lung Diseases
5%
Chemical Compounds
Citalopram
69%
Serotonin
51%
Structure-Activity Relationship
30%
Monoamine
27%
Enantioselectivity
26%
Agent Interacting With Transmitter, Hormone or Drug Receptor
26%
Binding Site
18%
Probe
14%
Antagonist
10%
Disorder
10%
Antidepressant Agent
8%
Antidepressant
7%
Leucine
6%
Dopamine
6%
Escitalopram
5%
Enantiomer
5%